These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27030325)

  • 1. [Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules].
    Makarova EV; Varvarina GN; Menkov NV; Czapaeva MY; Lazareva ES; Kazatskaya ZA; Novikov VV; Karaulov AV
    Ter Arkh; 2016; 88(3):24-31. PubMed ID: 27030325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
    Maltais F; Ostinelli J; Bourbeau J; Tonnel AB; Jacquemet N; Haddon J; Rouleau M; Boukhana M; Martinot JB; Duroux P
    Am J Respir Crit Care Med; 2002 Mar; 165(5):698-703. PubMed ID: 11874817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized Corticosteroids in the Treatment of COPD Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective.
    Pleasants RA; Wang T; Xu X; Beiko T; Bei H; Zhai S; Drummond MB
    Respir Care; 2018 Oct; 63(10):1302-1310. PubMed ID: 30237276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
    Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
    Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Gu YL; Pang J; Sun ZX; Hu J; Sun Y; Wu XW; Guo JJ; Yang GS
    J Clin Pharm Ther; 2020 Jun; 45(3):419-429. PubMed ID: 31954070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of nebulized budesonide in severe exacerbation of bronchial asthma].
    Sereda VP; Svistov AS
    Klin Med (Mosk); 2004; 82(6):61-6. PubMed ID: 15344695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled steroids in exacerbations of COPD.
    Singh A
    Eur Respir J; 2007 Aug; 30(2):398; author reply 399-400. PubMed ID: 17666566
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of nebulised budesonide in the treatment of exacerbations of COPD.
    Gunen H; Hacievliyagil SS; Yetkin O; Gulbas G; Mutlu LC; In E
    Eur Respir J; 2007 Apr; 29(4):660-7. PubMed ID: 17251232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
    Gunen H; Mirici A; Meral M; Akgün M
    Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
    Cazzola M
    Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
    Fukuchi Y; Samoro R; Fassakhov R; Taniguchi H; Ekelund J; Carlsson LG; Ichinose M
    Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma.
    Matthews EE; Curtis PD; McLain BI; Morris LS; Turbitt ML
    Acta Paediatr; 1999 Aug; 88(8):841-3. PubMed ID: 10503682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis.
    Zheng JP; Zhang J; Ma LJ; Chen P; Huang M; Ou XM; Zhao ZW; Jiang SJ; Cao J; Yao W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2725-2731. PubMed ID: 31819404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
    Cazzola M; Noschese P; De Michele F; D'Amato G; Matera MG
    Respir Med; 2006 Feb; 100(2):212-7. PubMed ID: 15936184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis.
    Jiang DH; Wang X; Liu LS; Ji DD; Zhang N
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5211-5216. PubMed ID: 29228436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.